COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study

Allsup, David; Howard, Dena; Emmerson, Jake; Hockaday, Anna; Rawstron, Andy; Oughton, Jamie B.; Bloor, Adrian; Phillips, David; Nathwani, Amit; Paneesha, Shankara; Turner, Deborah; Munir, Talha; Hillmen, Peter

doi:10.1111/bjh.17526

COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study

Allsup, David; Howard, Dena; Emmerson, Jake; Hockaday, Anna; Rawstron, Andy; Oughton, Jamie B.; Bloor, Adrian; Phillips, David; Nathwani, Amit; Paneesha, Shankara; Turner, Deborah; Munir, Talha; Hillmen, Peter

Authors

Professor David Allsup D.J.Allsup@hull.ac.uk
Professor of Haematology

Dena Howard

Jake Emmerson

Anna Hockaday

Andy Rawstron

Jamie B. Oughton

Adrian Bloor

David Phillips

Amit Nathwani

Shankara Paneesha

Deborah Turner

Talha Munir

Peter Hillmen

Citation

Allsup, D., Howard, D., Emmerson, J., Hockaday, A., Rawstron, A., Oughton, J. B., Bloor, A., Phillips, D., Nathwani, A., Paneesha, S., Turner, D., Munir, T., & Hillmen, P. (in press). COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study. British journal of haematology, https://doi.org/10.1111/bjh.17526

Journal Article Type	Article
Acceptance Date	Mar 12, 2021
Online Publication Date	May 24, 2021
Deposit Date	May 24, 2021
Publicly Available Date	May 25, 2022
Journal	British Journal of Haematology
Print ISSN	0007-1048
Publisher	Wiley
Peer Reviewed	Peer Reviewed
DOI	https://doi.org/10.1111/bjh.17526
Keywords	Chronic lymphocytic leukaemia; Chemotherapy; Clinical trial; Monoclonal antibody; Minimal residual disease
Public URL	https://hull-repository.worktribe.com/output/3773457